Discovery of Human-Similar Gene Fusions in Canine Cancers.

Canine cancers represent a tremendous natural resource due to their incidence and striking similarities to human cancers, sharing similar clinical and pathologic features as well as oncogenic events, including identical somatic mutations. Considering the importance of gene fusions as driver alterations, we explored their relevance in canine cancers. We focused on three distinct human-comparable canine cancers representing different tissues and embryonic origins. Through RNA-Seq, we discovered similar gene fusions as those found in their human counterparts: IGK-CCND3 in B-cell lymphoma, MPB-BRAF in glioma, and COL3A1-PDGFB in dermatofibrosarcoma protuberans-like. We showed not only similar partner genes but also identical breakpoints leading to oncogene overexpression. This study demonstrates similar gene fusion partners and mechanisms in human-dog corresponding tumors and allows for selection of targeted therapies in preclinical and clinical trials with pet dogs prior to human trials, within the framework of personalized medicine. Cancer Res; 77(21); 5721-7. ©2017 AACR.

[1]  Mark Dewhirst,et al.  Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology , 2016, Science Translational Medicine.

[2]  H. Uezato,et al.  A Novel Chromosomal Translocation Associated With COL1A2-PDGFB Gene Fusion in Dermatofibrosarcoma Protuberans: PDGF Expression as a New Diagnostic Tool. , 2015, JAMA dermatology.

[3]  Matthew Breen,et al.  Comparative oncology: what dogs and other species can teach us about humans with cancer , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[4]  B. Johansson,et al.  The emerging complexity of gene fusions in cancer , 2015, Nature Reviews Cancer.

[5]  K. Kurian,et al.  Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas , 2015, Front. Oncol..

[6]  R. Sciorsci,et al.  In vivo model for mastocytosis: A comparative review. , 2015, Critical reviews in oncology/hematology.

[7]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[8]  W. J. Hunter,et al.  Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature , 2014, Clinical Sarcoma Research.

[9]  David Cherba,et al.  Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials , 2014, PloS one.

[10]  M. Sanson,et al.  KIAA1549‐BRAF Fusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults , 2012, Brain Pathology.

[11]  C. E. Alvarez,et al.  Dog models of naturally occurring cancer. , 2011, Trends in molecular medicine.

[12]  H. Lo.  Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. , 2010, Current cancer drug targets.

[13]  H. Pospíšilová,et al.  Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas. , 2008, Blood.

[14]  M. Paoloni,et al.  Translation of new cancer treatments from pet dogs to humans , 2008, Nature Reviews Cancer.

[15]  J. Modiano,et al.  Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans – man and his best friend share more than companionship , 2008, Chromosome Research.

[16]  U. Jaeger,et al.  Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  F Solé,et al.  Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. , 2001, Blood.

[18]  M. Pierotti,et al.  Growth‐inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement , 2001, International journal of cancer.

[19]  H. Kishima,et al.  Usefulness of a Mouse Myelin Basic Protein Promoter for Gene Therapy of Malignant Glioma: Myelin Basic Protein Promoter Is Strongly Active in Human Malignant Glioma Cells , 1997, Japanese journal of cancer research : Gann.

[20]  J. Dumanski,et al.  Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastoma , 1997, Nature Genetics.